PSTV

#4451
PLUS THERAPEUTICS, Inc. Common Stock
5.65 USD
+4.05%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
5.65
5.65
Rango anual
0.13
6.02
Cambio diario
+4.05%
Variación mensual
+1992.59%
Variación en los últimos 6 meses
+743.28%
Cambio anual
+826.23%
Cierres anteriores
5.43
Abrir
5.65
Bid
Ask
Mínimo
5.65
High
5.65
Volumen
16
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25

PLUS THERAPEUTICS Inc

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®.

Noticias